Back to Startups

Affinia Therapeutics

About Affinia Therapeutics

Affinia Therapeutics is an innovative biotechnology company pioneering adeno-associated virus (AAV) gene therapies. The company focuses on developing transformative therapies for heart and nervous system diseases, utilizing artificial intelligence to design novel capsids that enhance the efficacy and safety of gene therapies.

Business Information
Target Customers
healthcare providers research institutions biopharmaceutical companies
Industry Categories
Bioscience & Disease Healthcare Systems AI, ML, Gen AI
Business Model
Revenue Model B2B partnerships and collaborations
Pricing Strategy N/A
Sales Channels direct sales, partnerships
Funding Timeline
Round Date Amount Investors
Series C Oct 08, 2025 $40.0M Unknown
Founders

No founder information available.

Investors

No investor information available.

Recent Mentions
raisingfi
Raising.fi @raisingfi
Oct 08, 2025

New Raise 🏛️ Company: Affinia Therapeutics 🔗 Website: https://t.co/UmzHBcvFeX 📊 Amount: $40 Million 🔄 Round: Series C 🧮 Valuation: N/A ⚙️ Industry: Biotechnology